Overview

Update
Status
Acquired by on January 11, 2011
Total Equity Funding
$91.5M in 3 Rounds from 9 Investors
Headquarters:
Basel, Basel-Stadt
Description:
Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.
Categories:
Therapeutics, Biotechnology, Medical
Website:
http://www.synosia.com

Company Details

Update

Synosia Therapeutics develops and intends to commercialise products for unmet medical needs in psychiatry and neurology. The privately-owned company has in its pipeline six clinical-stage compounds acquired through partnerships with Novartis, Roche and Syngenta. Two of the compounds are marketed drugs being tested in new indications to extend their reach into neurological and psychiatric diseases with high unmet medical need, including anxiety and Parkinson's disease.

Funding Rounds (3) - $91.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2010$30M / Series C7
Jan, 2009$29M / Series B7
Jan, 2007$32.5M / Venture4

Current Team (2)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    Aeschenvorstadt 36

    CH-4051

    Basel, Basel-Stadt

    Switzerland

Past Team (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos